High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK<sub>Ca</sub>-Channel Activity and Inhibits <i>I</i><sub>K(M)</sub> or <i>I</i><sub>h</sub>

GAL-021 has recently been developed as a novel breathing control modulator. However, modifications of ionic currents produced by this agent remain uncertain, although its efficacy in suppressing the activity of big-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> (BK<su...

Full description

Bibliographic Details
Main Authors: Te-Ling Lu, Zi-Han Gao, Shih-Wei Li, Sheng-Nan Wu
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/2/188
id doaj-7247e4c988f541f69200dd439d464f88
record_format Article
spelling doaj-7247e4c988f541f69200dd439d464f882020-11-25T03:32:00ZengMDPI AGBiomolecules2218-273X2020-01-0110218810.3390/biom10020188biom10020188High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK<sub>Ca</sub>-Channel Activity and Inhibits <i>I</i><sub>K(M)</sub> or <i>I</i><sub>h</sub>Te-Ling Lu0Zi-Han Gao1Shih-Wei Li2Sheng-Nan Wu3School of Pharmacy, China Medical University, Taichung City 40402, TaiwanDepartment of Physiology, National Cheng Kung University Medical College, Tainan City 70101, TaiwanDepartment of Physiology, National Cheng Kung University Medical College, Tainan City 70101, TaiwanDepartment of Physiology, National Cheng Kung University Medical College, Tainan City 70101, TaiwanGAL-021 has recently been developed as a novel breathing control modulator. However, modifications of ionic currents produced by this agent remain uncertain, although its efficacy in suppressing the activity of big-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> (BK<sub>Ca</sub>) channels has been reported. In pituitary tumor (GH<sub>3</sub>) cells, we found that the presence of GAL-021 decreased the amplitude of macroscopic Ca<sup>2+</sup>-activated K<sup>+</sup> current (<i>I</i><sub>K(Ca)</sub>) in a concentration-dependent manner with an effective IC<sub>50</sub> of 2.33 &#956;M. GAL-021-mediated reduction of <i>I</i><sub>K(Ca)</sub> was reversed by subsequent application of verteporfin or ionomycin; however, it was not by that of diazoxide. In inside-out current recordings, the addition of GAL-021 to the bath markedly decreased the open-state probability of BK<sub>Ca</sub> channels. This agent also resulted in a rightward shift in voltage dependence of the activation curve of BK<sub>Ca</sub> channels; however, neither the gating charge of the curve nor single-channel conductance of the channel was changed. There was an evident lengthening of the mean closed time of BK<sub>Ca</sub> channels in the presence of GAL-021, with no change in mean open time. The GAL-021 addition also suppressed M-type K<sup>+</sup> current with an effective IC<sub>50</sub> of 3.75 &#956;M; however, its presence did not alter the amplitude of <i>erg</i>-mediated K<sup>+</sup> current, or mildly suppressed delayed-rectifier K<sup>+</sup> current. GAL-021 at a concentration of 30 &#956;M could also suppress hyperpolarization-activated cationic current. In HEK293T cells expressing <i>&#945;-hSlo</i>, the addition of GAL-021 was also able to suppress the BK<sub>Ca</sub>-channel open probabilities, and GAL-021-mediated suppression of BK<sub>Ca</sub>-channel activity was attenuated by further addition of BMS-191011. Collectively, the GAL-021 effects presented herein do not exclusively act on BK<sub>Ca</sub> channels and these modifications on ionic currents exert significant influence on the functional activities of electrically excitable cells occurring in vivo.https://www.mdpi.com/2218-273X/10/2/188gal-021ca<sup>2+</sup>-activated k<sup>+</sup> currentlarge-conductance ca<sup>2+</sup>-activated k<sup>+</sup> channelm-type k<sup>+</sup> currentpituitary tumor cells<i>α-hslo</i>
collection DOAJ
language English
format Article
sources DOAJ
author Te-Ling Lu
Zi-Han Gao
Shih-Wei Li
Sheng-Nan Wu
spellingShingle Te-Ling Lu
Zi-Han Gao
Shih-Wei Li
Sheng-Nan Wu
High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK<sub>Ca</sub>-Channel Activity and Inhibits <i>I</i><sub>K(M)</sub> or <i>I</i><sub>h</sub>
Biomolecules
gal-021
ca<sup>2+</sup>-activated k<sup>+</sup> current
large-conductance ca<sup>2+</sup>-activated k<sup>+</sup> channel
m-type k<sup>+</sup> current
pituitary tumor cells
<i>α-hslo</i>
author_facet Te-Ling Lu
Zi-Han Gao
Shih-Wei Li
Sheng-Nan Wu
author_sort Te-Ling Lu
title High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK<sub>Ca</sub>-Channel Activity and Inhibits <i>I</i><sub>K(M)</sub> or <i>I</i><sub>h</sub>
title_short High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK<sub>Ca</sub>-Channel Activity and Inhibits <i>I</i><sub>K(M)</sub> or <i>I</i><sub>h</sub>
title_full High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK<sub>Ca</sub>-Channel Activity and Inhibits <i>I</i><sub>K(M)</sub> or <i>I</i><sub>h</sub>
title_fullStr High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK<sub>Ca</sub>-Channel Activity and Inhibits <i>I</i><sub>K(M)</sub> or <i>I</i><sub>h</sub>
title_full_unstemmed High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BK<sub>Ca</sub>-Channel Activity and Inhibits <i>I</i><sub>K(M)</sub> or <i>I</i><sub>h</sub>
title_sort high efficacy by gal-021: a known intravenous peripheral chemoreceptor modulator that suppresses bk<sub>ca</sub>-channel activity and inhibits <i>i</i><sub>k(m)</sub> or <i>i</i><sub>h</sub>
publisher MDPI AG
series Biomolecules
issn 2218-273X
publishDate 2020-01-01
description GAL-021 has recently been developed as a novel breathing control modulator. However, modifications of ionic currents produced by this agent remain uncertain, although its efficacy in suppressing the activity of big-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> (BK<sub>Ca</sub>) channels has been reported. In pituitary tumor (GH<sub>3</sub>) cells, we found that the presence of GAL-021 decreased the amplitude of macroscopic Ca<sup>2+</sup>-activated K<sup>+</sup> current (<i>I</i><sub>K(Ca)</sub>) in a concentration-dependent manner with an effective IC<sub>50</sub> of 2.33 &#956;M. GAL-021-mediated reduction of <i>I</i><sub>K(Ca)</sub> was reversed by subsequent application of verteporfin or ionomycin; however, it was not by that of diazoxide. In inside-out current recordings, the addition of GAL-021 to the bath markedly decreased the open-state probability of BK<sub>Ca</sub> channels. This agent also resulted in a rightward shift in voltage dependence of the activation curve of BK<sub>Ca</sub> channels; however, neither the gating charge of the curve nor single-channel conductance of the channel was changed. There was an evident lengthening of the mean closed time of BK<sub>Ca</sub> channels in the presence of GAL-021, with no change in mean open time. The GAL-021 addition also suppressed M-type K<sup>+</sup> current with an effective IC<sub>50</sub> of 3.75 &#956;M; however, its presence did not alter the amplitude of <i>erg</i>-mediated K<sup>+</sup> current, or mildly suppressed delayed-rectifier K<sup>+</sup> current. GAL-021 at a concentration of 30 &#956;M could also suppress hyperpolarization-activated cationic current. In HEK293T cells expressing <i>&#945;-hSlo</i>, the addition of GAL-021 was also able to suppress the BK<sub>Ca</sub>-channel open probabilities, and GAL-021-mediated suppression of BK<sub>Ca</sub>-channel activity was attenuated by further addition of BMS-191011. Collectively, the GAL-021 effects presented herein do not exclusively act on BK<sub>Ca</sub> channels and these modifications on ionic currents exert significant influence on the functional activities of electrically excitable cells occurring in vivo.
topic gal-021
ca<sup>2+</sup>-activated k<sup>+</sup> current
large-conductance ca<sup>2+</sup>-activated k<sup>+</sup> channel
m-type k<sup>+</sup> current
pituitary tumor cells
<i>α-hslo</i>
url https://www.mdpi.com/2218-273X/10/2/188
work_keys_str_mv AT telinglu highefficacybygal021aknownintravenousperipheralchemoreceptormodulatorthatsuppressesbksubcasubchannelactivityandinhibitsiiisubkmsuboriiisubhsub
AT zihangao highefficacybygal021aknownintravenousperipheralchemoreceptormodulatorthatsuppressesbksubcasubchannelactivityandinhibitsiiisubkmsuboriiisubhsub
AT shihweili highefficacybygal021aknownintravenousperipheralchemoreceptormodulatorthatsuppressesbksubcasubchannelactivityandinhibitsiiisubkmsuboriiisubhsub
AT shengnanwu highefficacybygal021aknownintravenousperipheralchemoreceptormodulatorthatsuppressesbksubcasubchannelactivityandinhibitsiiisubkmsuboriiisubhsub
_version_ 1724570331752955904